14. Oncología - Sociedad Española de Farmacia Hospitalaria

1226 FARMACIA HOSPITALARIAration by pretreatment with ICRF 187 in syriangolden hamsters. Cancer Treat Rep 1979; 63:89-92.140. Hellmann K. Cardioprotection by dexrazoxane(cardioxane; ICRF 187): progress in supportive care.Supp Care Cancer 1996; 4:305-307.141. Swain S, Whaley FS, Gerber MC, et al. Delayed administrationof dexrazoxane provides cardioprotectionfor patients with advanced breast cancertreated with doxorubicine-containing chemotherapy.J Clin Oncol 1997; 15: 1333-1340.142. Schuchter LM. Current role of protective agentsin cancer treatment. Oncology 1996; 11:505-516.143. Capizzi RL. The preclinical basis for broad-spectrumselective cytoprotection of normal tissuesfrom cytotoxic therapies by amifostine (Ethyol).Eur J Cancer 196; 32:5-16.144. Schuchter LM. Guidelines for the administrationof amifostine. Semin Oncol 1996; 23:40-43.145. Bukowski RM. Amifostine (Ethyol): dosing, administrationand patient management guidelines.Eur J Cancer 1996; 32:46-49.146 Ryan SV, Carrithers SL, Parkinson SJ , et al. Hypotensivemechanisms of amifostine. J Clin Pharmacol1996; 36:365-373.147. International Association for the Study of Pain(IASP). Subcommittee on Taxonomy. Pain terms:a list with definitions and notes on usage. Pain1980; 8:249-52.148. Twycross, R.G. Symptom control in terminal cancer.Ed. Sir Michael Sobell House. Churchill Hospital.Oxford. 1990.149. Curtis EB, Krech R, Walsh TD. Commonsymptoms in patients with advanced cancer. J PalliatCare. 1991 Summer; 7(2):25-9.150. Foley KM. Pain assessment and cancer painsyndromes. En Doyle D,Hanks G. and Mac DonaldN, editors. Oxford Textbook of Palliative Medicine.2ª ed. Oxford; Oxford University Press;1998; 310-31.151. Bonica JJ, Benedetti C. Management of Cancerpain. En: Comprehensive textbook of Oncology.Ed. Moosa AR, Robson MC, Schempff CC. Baltimore.Williams and Wilkins. 1986; 444.152. Murillo E, Duque A, Virizuela JA. Tratamientoetiológico o causal del dolor oncológico. En: SanzOrtiz J. ed. El control del sufrimiento evitable. Terapiaanalgésica. Ed. You & Us, S.A. Madrid 2001.153. Bonica JJ. Treatment of cancer pain: current statusand future needs. En: Fields, HL, Dubner R,Cervero F. Advances in pain research and therapy,vol 9; 589-616. Proceeding of the Fourth WorldConference on Pain. New York; Raven Press;1985 (3) Bonica JJ. Importance of the problem. InCancer Pain. Ed. M. Swerdlow and V. Ventafridda.MTP Press Limited. Lancaster. England. 1987;3-8.154. Twycross RG. Pain in far advanced cancer. Pain1982; 14:303-310.155. Saunders CM. The management of terminal illness.Hospital Medicine Publication. London1967.156. Astudillo W, Mendinueta C. Bases para el tratamientodel dolor del enfermo en la fase terminal.En: Astudillo W, Mendinueta C, Astudillo E, editores.Cuidados del enfermo en fase terminal yatención a su familia. Navarra; Ediciones Universidadde Navarra S.A. 1995; 187-198.157. World Health Organization. Cancer Pain relief.Ed. WHO. Geneve. 1986.158. Hanks GWC, De Conno F, Ripamonti C, et al.Expert Working Group of the European Associationfor Palliative Care. Morphine in cancerpain: modes of administration. British MedicalJournal 1996; 312:823-826.159. Maloney C; Kesner RK; Klein G, et al. Rectal administrationof MS Contin: Clinical implicationsof use in end stage cancer. The Am. J. of HospiceCare 1989; 6 (4): 34-35.160. Kaiko RF, Healy N, Pav J, et al. The comparativebioavailability of MS Contin tablets following rectaland oral administration. Royal Society of Medicine.International Congress and Symposium Series.1989; 149:235-41.161. Waller A, Caroline NL,editores. Handbook of palliativecare in cancer. Newton (USA): Butterworth-Heinemann;1996.162. Gómez-Batiste X, Gómez M, Codorniu N, et al.Recomendaciones prácticas para el uso de morfina.Medicina Paliativa 1995; 2(3):20-32.163. Twycross, R.G. and Lack, S.A. Therapeutics in terminalcancer. 20 Ed. New York. Churchill Livingstone.1990.164. Sanz Ortiz J. Fentanilo transdérmico: reservoriocutáneo fentanilo (RCP). En: Sanz Ortiz J. ed. Elcontrol del sufrimiento evitable. Terapia analgésica.Ed. You & Us, S.A. Madrid 2001.